15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 17 firms covering Healthpeak Properties Inc, 5 rate it Buy or better, 12 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $17.00 to $24.00, a moderate spread. The average target of $21.53 sits 5% above the current $20.52. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 4 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.03 next quarter toward $0.14 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS17 ratings
Moderate Buy
Strong Buy00%
Buy529%
Hold1271%
Sell00%
Strong Sell00%
Based on 17 analysts giving stock ratings to Healthpeak Properties Inc.
As of Sep, 5 of 17 firms rate DOC a Buy (12 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
DOC EPS & revenue forecast
EPS · NEXT QUARTER
$0.03
Range $0.02 – $0.04 · 2 analysts · -69% YoY
Next period, 2 analysts expect Healthpeak Properties Inc to earn $0.03 a share (range $0.02 – $0.04), versus $0.10 a year earlier. Full-year consensus is $0.09, growing to $0.14 the year after.
REVENUE · NEXT QUARTER
$769.6M
Range $733.4M – $805.1M · 2 analysts · +9% YoY
Revenue is expected to reach $769.6M (range $733.4M – $805.1M), +9.2% year-over-year. Full-year consensus is $2.9B, rising to $3.1B next year.
Top analysts covering Healthpeak Properties Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DOC.
#1
Nicholas Yulico
Scotiabank · Rank #68
Hold
$21.00+2.4% to target
Overall win rate
51%
+ Follow
#2
John Kilichowski
Wells Fargo · Rank #116
Hold
$22.00+7.2% to target
Overall win rate
46%
+ Follow
#3
AS
Amanda Sweitzer
Baird
Buy
$24.00+17.0% to target
Coverage
—
+ Follow
#4
JK
James Kammert
Evercore ISI Group
Hold
$23.00+12.1% to target
Coverage
—
+ Follow
#5
Richard Anderson
Cantor Fitzgerald
Hold
$23.00+12.1% to target
Coverage
—
+ Follow
DOC stock forecast FAQ
What is DOC's average 12-month price target?+
The 15 analysts with a live target average $21.53 for Healthpeak Properties Inc over the next 12 months, ranging from a $24.00 high to a $17.00 low.
Is DOC stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 17 analyst ratings, 5 are Buy or Strong Buy, 12 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for DOC?+
The Street-high target is $24.00 (Baird), and the Street-low is $17.00 (Goldman Sachs). The average of all 15 active targets is $21.53.
How many Wall Street analysts cover DOC?+
17 analysts have an active rating on Healthpeak Properties Inc, and 15 firms carry a live 12-month price target.
Who is the most accurate analyst covering DOC?+
Among analysts who currently cover DOC, Nicholas Yulico of Scotiabank has the strongest overall Quantellect track record (Rank #68). Their current call is Hold with a $21.00 target.
What is Healthpeak Properties Inc's projected EPS for next quarter?+
The consensus estimate is $0.03 per share (range $0.02 – $0.04) across 2 analysts. Full-year EPS is projected at $0.09, rising to $0.14 the following year.
How much revenue is Healthpeak Properties Inc expected to report next quarter?+
Consensus revenue is $769.6M (range $733.4M – $805.1M). Full-year revenue is projected at $2.9B, growing to $3.1B next year.
Have analysts been upgrading or downgrading DOC lately?+
As of Sep, 5 of 17 firms rate DOC a Buy (12 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DOC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
Raymond James
